NorthWest Biotherapeutics Inc (NWBO)

[TheFollower]

Estimated Timeline: CHM Recommendation to MHRA Notification
Event Estimated Date Range
CHM Meeting July 24–25, 2025
MHRA Final Decision ~August 1–15, 2025
Notification to NWBO Same day as MHRA decision
NWBO Public Disclosure ~1–2 business days after notification
What This Means for DCVax-L
If CHM issued a positive recommendation on July 25, MHRA would typically finalize its decision within 7 to 14 calendar days.
That puts the likely MHRA notification window between August 1 and August 8.
NWBO, being a publicly traded company, would be expected to announce the approval within 24–48 hours of receiving formal notice — so potentially as early as August 2–10, depending on internal coordination.
This aligns with MHRA’s recent NAS approval patterns, where the post-CHM turnaround has averaged 10 days. If DCVax-L follows suit, we’re right on the cusp of a potential announcement window.

Possibility of CHM recommendation for approval. - Copilot